Daniela Trabattoni

After obtaining a degree in Medicine and Surgery from the University of Milan in 1992, he specialized in Cardiology at the University of Milan in 1997. In the period 1997-1998, he completed a Fellowship in Intracoronary Imaging at the Washington Hospital Center in Washington, DC. Since 1998, he has been attending the Monzino Cardiology Center as an assistant physician in the Interventional Cardiology Unit where he became a Senior Assistant in 2008 and a Referring Physician in 2014. In January 2017, he established the Women Heart Center for cardiovascular prevention in women at the Monzino Cardiology Center and since October 2017, he has been directing the Invasive Cardiology Operational Unit 3 at the same Institute.

He is a tutor for students in the Medicine and Surgery course - University of Milan.

Teacher at the Specialization School in Cardiovascular Pathologies at the University of Milan.

She was appointed as a member of the commission for the evaluation of cardiovascular devices at the Istituto Superiore di Sanità (2011) and as a member of the Commission of the Istituto Superiore di Sanità (2018) for the drafting of the ministerial document for the implementation and dissemination of Gender Medicine (in implementation of Article 3, paragraph 1, Law 3/2018).

Scientific Results

Daniela Trabattoni's research activity focuses mainly on the field of Interventional Cardiology, investigating the factors that can influence the outcome of coronary revascularization based on the use of different types of coronary stents, also focusing on gender-based analysis. She has deepened the effects of cardioprotective therapies used during acute myocardial infarction as adjuvants to primary angioplasty in the functional recovery of the left ventricle. She has explored the potential correlations between patent foramen ovale and migraines and conducted comparative analyses between different occlusive devices for the percutaneous correction of PFO. She worked on drafting the consensus document of the Society of Invasive Cardiology for the management of antiplatelet therapy in patients undergoing coronary revascularization and directed to urgent or elective surgery. She conducted studies to evaluate the safety and efficacy of short-duration antiplatelet treatment after implantation of medicated or drug-coated coronary stents in patients at high risk of bleeding.

He has participated in numerous international projects.

• Acute and 30-day outcomes in women after TAVR: Results from the WIN-TAVI (Women’s International Transcatheter Aortic Valve Implantation) Real World Registry. JACC Cardiovasc Interv . 2016
• Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical, and anesthesiological societies. Eurointervention, 2014;
• Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registry. EuroIntervention, 2013.

Editorial activities and publications

He is a reviewer for international and national cardiology journals (Italian Journal of Cardiology, Journal of Cardiovascular Medicine, International Journal of Cardiology, Catheterization and Cardiovascular Interventions, Cephalalgia, Circulation Cardiovascular Interventions).

Member of Editorial Board: J Endovasc Therapy (2010-2013); Journal of Hypertension and Immunotherapy

She is the author and co-author of 518 publications (114 full papers, 400 abstracts, 4 book chapters) in national and international journals, including:

1. D. Trabattoni, A. Bartorelli, P.Montorsi, F. Fabbiocchi, A. Loaldi, S. Galli, P. Ravagnani, S. Cozzi, L. Grancini, A. Liverani, M.E. Leon, C. Robertson, P. Boyle. Comparison of outcomes in women and men treated with coronary stent implantation. Cathet Cardiovasc Intervent, 2003; 58:20-28.
2. D. Trabattoni, F. Fabbiocchi, P. Montorsi, G. Calligaris, S. Galli, P. Ravagnani, S. De Martini, G. Teruzzi, A.L. Bartorelli. Angiographic patterns of in-stent restenosis in men and women. Ital Heart J, 2005; 6 (2).138-142.
3. D. Trabattoni, AL. Bartorelli, F. Fabbiocchi, P. Montorsi, P. Ravagnani, M. Pepi, F. Celeste, A. Maltagliati, G. Marenzi, W.O’Neill. Hyperoxemic perfusion of left anterior descending coronary artery after primary angioplasty in anterior ST-elevation myocardial infarction. Cathet and Cardiovasc Interv, 2006; 67:859-865. DOI: 10.1002/ccd.20704
4. D. Trabattoni, F. Fabbiocchi, P. Montorsi, P. Ravagnani, S. Galli, G. Teruzzi, G. Calligaris, S. De Martini, AL Bartorelli. Stent thrombosis after sirolimus- and paclitaxel-eluting stent implantation in daily clinical practice: analysis of a single center registry. Cath Cardiovasc Interv, 2007; 70 (3): 415-421. DOI 10.1002/ccd.21149
5. D. Trabattoni, F. Fabbiocchi, P. Montorsi, S. Galli, G. Teruzzi, L. Grancini, P. Gatto, A.L. Bartorelli. Sustained long-term benefit of PFO closure on migraine. Cath Cardiovasc Interv, 2011; 77 (4):570-574. doi: 10.1002/ccd.22826
6. D. Trabattoni, P. Montorsi, F. Fabbiocchi, A. Lualdi, P. Gatto, A.L. Bartorelli. A new kaolin-based haemostatic bandage compared with manual compression for bleeding control after percutaneous coronary procedures. European Radiology, 2011; 21(8):1687-91. doi: 10.1007/s00330-011-2117-3. Epub 2011 Apr 9.
7. D. Trabattoni, A. Bartorelli . IVUS in bifurcation stenting: what have we learned? Eurointervention suppl 2010; 6: J88-J93. doi: 10.4244/EIJV6SUPJA14
8. D. Trabattoni, F. Fabbiocchi, S. Galli, P. Montorsi, A. Lualdi, L. Grancini, Ravagnani, A.L. Bartorelli. Sex difference in long-term clinical outcome after sirolimus-eluting stent implantation . Coron Artery Dis, 2011; 22(6):442-6. DOI 10.1097/MCA.0b013e3283475056
9. Taddei S, Trabattoni D. The Symplicity HTN-3 study. Ital Cardiol . 2014 Sep;15(9):460- 4. doi: 10.1714/1640.17968.
10. D. Trabattoni, F. Fabbiocchi, P. Olivares, G. Basadonna, G. Calligaris, A. Bartorelli. A kaolin-based hemostatic gauze as an adjunctive tool for bleeding control after vascular closure devices use in TAVI patients. Int J Rec Scient Res, 2015; 6 (3):2919-2921
11. Bartorelli AL, Trabattoni D, Almonacid A, Fabbiocchi F, Montorsi P, Galli S, Grancini L, Ravagnani P, Mintz GS, Kaplan AV, Popma JJ, Maehara A. Serial intravascular ultrasound analysis of complex bifurcation coronary lesions treated with the Tryton bifurcation stent in conjunction with an everolimus-eluting stent: IUVANT (intravascular ultrasound evaluation of tryton stent) study. Catheter Cardiovasc Interv. 2015; 85(4):544-53. doi: 10.1002/ccd.25629.
12. Trabattoni D, Gaspardone A, Sgueglia GA, Fabbiocchi F, Gioffrè G, Montorsi P, Calligaris G, Iamele M, De Santis A, Bartorelli AL. AMPLATZER versus Figulla occluder for transcatheter patent foramen ovale closure. EuroIntervention. 2017;12(17):2092-2099. doi: 10.4244/EIJ-D-15-00499.
13. Trabattoni D, Fabbiocchi F, Montorsi P, Galli S, Ravagnani P, Calligaris G, Teruzzi G, Grancini L, Troiano S, Ferrari C, Bartorelli AL. A Long-term Single-center Registry of 6,893 Patients Undergoing Elective Percutaneous Coronary Intervention With the Xience Everolimus-Eluting Stent. J Invasive Cardiology, 2019; in press

Awards and recognition

• Fellow of the Italian Society of Cardiology (1995-present)
• Fellow of the European Society of Cardiology (August 2001-present)
• Member of the Italian Invasive Cardiology Group (2001-present)
• Fellow of the American College of Cardiology (February 2005-present)
• Member of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) (September 2007-present)
• Receives the Rosa Camuna award - Lombardy Region (2009).